Alice Goodman

Authored Items

Patient-Reported Outcomes Influence Radiation Guidelines

Alice Goodman

TON - September 2017, Vol 10, No 5 in Conference Correspondent

Hair Loss Seen in 1 of 3 Women with Breast Cancer Receiving Endocrine Therapy

Alice Goodman

TON - September 2017, Vol 10, No 5 in Conference Correspondent

Adverse Events Associated with Checkpoint Inhibitors

Alice Goodman

TON - September 2017, Vol 10, No 5 in Side-Effects Management, Side-Effects Management

Overcoming Cultural Barriers to Screening Access

Alice Goodman

TON - July 2017, Vol 10, No 4 in Conference Correspondent

CDK4/CDK6 Inhibitors Show Promise in Advanced Postmenopausal Breast Cancer

Alice Goodman

TON - July 2017, Vol 10, No 4 in Breast Cancer

Tackling Obesity and Excess Weight in Patients with Cancer

Alice Goodman

TON - July 2017, Vol 10, No 4 in Conference Correspondent

Turning the Tables: An Oncology Nurse Becomes a Patient with Cancer

Alice Goodman

TON - July 2017, Vol 10, No 4 in Conference Correspondent

CAR T-Cell Therapy: What to Expect

Alice Goodman

TON - July 2017, Vol 10, No 4 in Conference Correspondent

Managing Radiation-Related Side Effects in Patients with Human Papillomavirus–Associated Oral Cancer

Alice Goodman

TON - July 2017, Vol 10, No 4 in Side-Effects Management, Side-Effects Management

Nurse Navigation Program Improves Access and Satisfaction with Cancer Care

Alice Goodman

TON - July 2017, Vol 10, No 4 in Best Practices

Streamlining Project at Infusion Center Improves Efficiency

Alice Goodman

TON - July 2017, Vol 10, No 4 in Best Practices

Chemotherapy Discharge Education Class Improves Patient Safety

Alice Goodman

TON - July 2017, Vol 10, No 4 in Best Practices

Closing the Racial Divide for Curative Lung Cancer

Alice Goodman

TON - January 2017, Vol 10, No 1 in Conference Correspondent

Cognition and Depression Affect Adherence in Elderly Patients on Anticancer Drugs

Alice Goodman

TON - January 2017, Vol 10, No 1 in Supportive Care

Better Education Needed to Recognize and Manage Adverse Effects

Alice Goodman

TON - January 2017, Vol 10, No 1 in Conference Correspondent

Toxicities Associated with Targeted Therapy and Immunotherapy Underreported in Published Studies

Alice Goodman

TON - January 2017, Vol 10, No 1 in Supportive Care

Mounting Evidence for Ki67 as Independent Prognostic Marker

Alice Goodman

TON - January 2017, Vol 10, No 1 in Breast Cancer

Collaborative Oncology Care Requires Good Mentoring, Self-Study

Alice Goodman

TON - November 2016, Vol 9, No 6 in Best Practices

Quality of Life with Hypofractionated Radiotherapy in Patients with Low-Risk Prostate Cancer

Alice Goodman

TON - November 2016, Vol 9, No 6 in Conference Correspondent

Fewer Adverse Events with Intensity-Modulated Radiation Therapy for Patients with Gynecologic Cancers

Alice Goodman

TON - November 2016, Vol 9, No 6 in Conference Correspondent

ASCO 2016 Highlights

Alice Goodman

TON - September 2016, Vol 9, No 5 in Conference Correspondent

Conference News

Alice Goodman

TON May 2016 Vol 9 No 3 in Conference Correspondent

Identifying Patients with Cancer Who Need More Psychosocial Support

Alice Goodman

TON May 2016 Vol 9 No 3 in Conference Correspondent

Conference News

Alice Goodman

TON March 2016 Vol 9 No 2 in Conference Correspondent

Toxicity Profiles of Abiraterone, Enzalutamide, and Prednisone Should Inform Treatment Selection

Alice Goodman

TON March 2016 Vol 9 No 2 in Genitourinary Cancers

PROCLAIM Study Fails to Identify Best Regimen for Locally Advanced Lung Cancer

Alice Goodman

Online First in Lung Cancer, Online First

Considerations for Young Adults with Cancer

Alice Goodman

TON September 2015 Vol 8 No 5 in Best Practices

Managing Cytokine Release Syndrome

Alice Goodman

TON September 2015 Vol 8 No 5 in Best Practices

Management Options with Obinutuzumab

Alice Goodman

TON September 2015 Vol 8 No 5 in Best Practices

Boosting Uptake of the HPV Vaccine

Alice Goodman

TON July 2015 Vol 8 No 4 in Best Practices

Considerations with Use of Synribo After TKI Failure

Alice Goodman

TON July 2015 Vol 8 No 4 in Hematologic Cancers

Palliative Care and the Role of Nurses

Alice Goodman

TON July 2015 Vol 8 No 4 in Palliative Care

Management of Immunotherapy-Related Adverse Events

Alice Goodman

TON July 2015 Vol 8 No 4 in Supportive Care

Highlights from ASH and SABCS

Alice Goodman

TON - January 2015 Vol 8 No 1 in Conference Correspondent

Room for Improvement in Symptom Management

Alice Goodman

TON - November/December 2014 Vol 7 No 6 in Best Practices

Managing Patients Receiving Ibrutinib

Alice Goodman

TON - November/December 2014 Vol 7 No 6 in Hematologic Cancers

Infection Prophylaxis Update

Alice Goodman

TON - November/December 2014 Vol 7 No 6 in Best Practices

Highlights From the American Society for Radiation Oncology 2014 Annual Meeting

Alice Goodman

TON - November/December 2014 Vol 7 No 6 in Conference Correspondent

Highlights of the 2014 Annual Meeting of the American Society of Clinical Oncology

Alice Goodman

TON - September/October 2014 Vol 7 No 5 in Conference Correspondent

Gap in Lymphedema Awareness

Alice Goodman

TON - September/October 2014 Vol 7 No 5 in Breast Cancer

Sexuality Should Be Addressed With Cancer Patients

Alice Goodman

TON - September/October 2014 Vol 7 No 5 in Supportive Care

Caregivers Benefit From Immediate Versus Delayed Palliative Support

Alice Goodman

TON - July/August 2014 Vol 7 No 4 in Best Practices

Fertility Preservation Options for Patients With Cancer

Alice Goodman

TON - July/August 2014 Vol 7 No 4 in Supportive Care

Updates to ONS Chemotherapy and Biotherapy Guidelines

Alice Goodman

TON - May/June 2014 Vol 7 No 3 in Conference Correspondent

IOM Report on Cancer Care Decoded

Alice Goodman

TON - May/June 2014 Vol 7 No 3 in Conference Correspondent

ONS Exercise Campaign Aims to Improve Outcomes

Alice Goodman

TON - May/June 2014 Vol 7 No 3 in Conference Correspondent

Raising the Bar: 4 Drugs for CLL

Alice Goodman

TON - March/April 2014 Vol 7 No 2 in Hematologic Cancers

Brain Metastasis and End-of-Life Care in Metastatic Breast Cancer

Alice Goodman

TON - January/February 2014 Vol 7 No 1 in Breast Cancer

Addressing Psychosocial and Physical Fallout From Breast Cancer

Alice Goodman

TON - January/February 2014 Vol 7 No 1 in Breast Cancer

Antiangiogenesis Pursued in High-Risk Ovarian Cancer

Alice Goodman

TON - December 2013 Vol 6 No 11 in Gynecologic Cancers

Neoadjuvant Chemotherapy a Reasonable Option for Advanced Ovarian Cancer

Alice Goodman

TON - December 2013 Vol 6 No 11 in Gynecologic Cancers

Raising Awareness of Cancer Anorexia-Cachexia Syndrome in Patients With Lung Cancer

Alice Goodman

TON - November 2013 Vol 6 No 10 in Supportive Care

Update on Managing Dyspnea

Alice Goodman

TON - November 2013 Vol 6 No 10 in Supportive Care

Prostate Cancer in the News

Alice Goodman

TON - September 2013 Vol 6 No 8

Abiraterone in Untreated Metastatic Castration-Resistant Prostate Cancer: Longer-Term Analysis of Pivotal Trial Confirms Safety and Efficacy

Alice Goodman

TON - September 2013 Vol 6 No 8 in Genitourinary Cancers

Enzalutamide Promising in Hormone-Naive Prostate Cancer

Alice Goodman

TON - September 2013 Vol 6 No 8 in Genitourinary Cancers

The 2013 American Society of Clinical Oncology Annual Meeting

Alice Goodman

TON - July 2013 Vol 6 No 6 in Conference Correspondent

Progress in Primary and Secondary Prevention of HPV-Associated Noncervical Cancers

Alice Goodman

TON - July 2013 Vol 6 No 6

Tobacco Use Often Falls Through the Cracks in Oncology Practices

Alice Goodman

TON - July 2013 Vol 6 No 6 in Best Practices

Winship Cancer Institute of Emory University

Alice Goodman

TON - June 2013, Vol 6, No 5 in Cancer Center Profile

The 38th Annual Congress of the Oncology Nursing Society

Alice Goodman

TON - June 2013, Vol 6, No 5 in Conference Correspondent

Survivorship Plans: Taking Care of the Details

Alice Goodman

TON - June 2013, Vol 6, No 5 in Survivorship

Antibody-Conjugate Encouraging in Platinum-Resistant Ovarian Cancer

Alice Goodman

TON - June 2013, Vol 6, No 5 in Gynecologic Cancers

Breast, Colorectal, and Lung Cancer Screening Guidelines Explored

Alice Goodman

TON - June 2013, Vol 6, No 5 in Best Practices

Home-Grown Research Project to Screen for Malglycemia

Alice Goodman

TON - June 2013, Vol 6, No 5 in Best Practices

Oral Chemotherapy: What Does the Oncology Nurse Need to Know?

Alice Goodman

TON - June 2013, Vol 6, No 5 in Best Practices

Drug Combination Potentially Effective in BRCA-Deficient Solid Tumors

Alice Goodman

TON - June 2013, Vol 6, No 5

Genetic Analysis Identifies 4 Subsets of Squamous Cell Carcinoma of the Head and Neck

Alice Goodman

TON - June 2013, Vol 6, No 5 in Head and Neck Cancer

Incorporating Caregivers Improves Physical Activity and Quality of Life in Patients With Cancer

Alice Goodman

TON - June 2013, Vol 6, No 5 in Best Practices

Addressing Spiritual Concerns

Alice Goodman

TON - June 2013, Vol 6, No 5 in Supportive Care

Predicting Risk of Significant Side Effects With OnPART

Alice Goodman

TON - March 2013, Vol 6, No 2 in Supportive Care

54th Annual Meeting of the American Society of Hematology

Alice Goodman

TON - March 2013, Vol 6, No 2 in Conference Correspondent

New York-Presbyterian Hospital/Weill Cornell Medical Center

Alice Goodman

TON - March 2013, Vol 6, No 2 in Cancer Center Profile

Survival Benefit for ER-Negative Local Breast Cancer Recurrence

Alice Goodman

TON - February 2013, Vol 6, No 1 in Breast Cancer

Benefit for Neoadjuvant Chemotherapy Seen in Very Young Patients With Triple-Negative and Luminal-Like Breast Cancer

Alice Goodman

TON - February 2013, Vol 6, No 1 in Breast Cancer

Approaches to Sexual Dysfunction in Breast Cancer Survivors

Alice Goodman

TON - February 2013, Vol 6, No 1 in Supportive Care

Higher Doses of Fulvestrant Better Than Lower Doses

Alice Goodman

TON - February 2013, Vol 6, No 1 in Conference Correspondent

Extending Adjuvant Tamoxifen to 10 Years Improves Survival

Alice Goodman

TON - February 2013, Vol 6, No 1 in Conference Correspondent

Fox Chase Cancer Center

Alice Goodman

TON - October 2012 Vol 5 No 9 in Cancer Center Profile

John Theurer Cancer Center - Gold Standard of Care

Alice Goodman

TON - November 2012, Vol 5, No 10 in Cancer Center Profile

Highlights from the European Society for Medical Oncology

Alice Goodman

TON - November 2012, Vol 5, No 10 in Conference Correspondent

Preventing Chemotherapy-Induced Peripheral Neuropathy Remains Elusive

Alice Goodman

TON - November 2012, Vol 5, No 10 in Supportive Care

Chemotherapy-Induced Peripheral Neuropathy Increases Risk of Falls and Physical and Functional Problems, Especially in Older Patients

Alice Goodman

TON - September 2012 VOL 5, NO 8 in Supportive Care

Progress in Treating Prostate Cancer

Alice Goodman

TON - September 2012 VOL 5, NO 8 in Genitourinary Cancers

Surgery Versus Observation for Localized Prostate Cancer

Alice Goodman

TON - September 2012 VOL 5, NO 8

MDV3100 Extends Survival in Men With Advanced Prostate Cancer

Alice Goodman

TON - JULY 2012 VOL 5, NO 6 in Genitourinary Cancers

Late Effects of Treatment Common in Gastroesophageal Cancer Survivors

Alice Goodman

TON - JULY 2012 VOL 5, NO 6 in Gastrointestinal Cancers

Duloxetine in Peripheral Neuropathy

Alice Goodman

TON - JULY 2012 VOL 5, NO 6 in Conference Correspondent

Another Reason for Men With Prostate Cancer to Exercise

Alice Goodman

TON - JUNE 2012 VOL 5, NO 5 in Genitourinary Cancers

Mastectomy Risk Twice as High With Brachytherapy

Alice Goodman

TON - JUNE 2012 VOL 5, NO 5

Tumors More Heterogeneous Than Previously Recognized

Alice Goodman

TON - JUNE 2012 VOL 5, NO 5

Five-Year Follow-up of VISTA Trial Confirms Long-term Survival Benefit for Bortezomib-Containing Regimen Up Front

Alice Goodman

TON - Special Issue May 2012, Vol 5, No 4 in Hematologic Cancers

Pazopanib Potential Treatment for Refractory Urothelial Cancer

Alice Goodman

TON - Special Issue May 2012, Vol 5, No 4

CYP2D6 Genotyping Fails to Predict Effectiveness of Tamoxifen

Alice Goodman

TON - April 2012, Vol 5, No 3 in In the News

Morbidity of Hematopoietic Transplant

Alice Goodman

TON - MARCH 2012 VOL 5, NO 2 in Hematologic Cancers

CYP2D6 Genotyping Fails to Predict Effectiveness of Tamoxifen

Alice Goodman

Online First

Bone Biomarker Identified for Metastatic Prostate Cancer

Alice Goodman

TON - MARCH 2012 VOL 5, NO 2 in In the News

Long-term Implications of Oophorectomy

Alice Goodman

TON - MARCH 2012 VOL 5, NO 2 in Supportive Care

BOLERO-2: Practice-Changing Results With Exemestane Plus Everolimus in Advanced Breast Cancer

Alice Goodman

TON - MARCH 2012 VOL 5, NO 2 in Breast Cancer

Advances in the Treatment of Multiple Myeloma: Next-Generation Proteasome Inhibition

Alice Goodman

Online First

Spotlight on Compassion Fatigue for Oncology Nurses

Alice Goodman

TON - February 2012 VOL 5, No 1 in Best Practices

Gene Array Test for Predicting Recurrence Risk in DCIS

Alice Goodman

TON - February 2012 VOL 5, No 1 in Conference Correspondent, Conference Correspondent

Survivors With BRCA Mutations Are at Increased Risk of Contralateral Breast Cancer

Alice Goodman

TON - February 2012 VOL 5, No 1 in Conference Correspondent, Conference Correspondent

New Look at Discontinued Drug in Older Patients With Acute Myeloid Leukemia

Alice Goodman

TON - February 2012 VOL 5, No 1 in Conference Correspondent, Conference Correspondent

New Preventive Program for Latinas Unveiled

Alice Goodman

TON - February 2012 VOL 5, No 1 in Conference Correspondent, Conference Correspondent

Sexual Issues and Nurse’s Role: Just Ask!

Alice Goodman

Web Exclusives in Supportive Care

Management of Radiation-Induced Skin Reactions Up to Individual Practices

Alice Goodman

TON - December 2011, Vol 4, No 8 in In the News

Novel Drugs in Prostate Cancer

Alice Goodman

TON - March/April 2011, VOL 4, NO 2 in Genitourinary Cancers

Last modified: December 11, 2015